Selinexor with ruxolitinib for treating splenomegaly or symptoms in myelofibrosis untreated with a JAK inhibitor [TSID12341]

  • Awaiting development
  • GID-TA11941
  • Expected publication date: TBC

Register as a stakeholder

30609-Selinexor-Ruxolitinib-for-Myelofibrosis-V1.0-NOV2025-NON-CONF.pdf